Published in Obes Rev on July 18, 2011
Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline? J Diabetes Investig (2012) 1.30
Executive functions profile in extreme eating/weight conditions: from anorexia nervosa to obesity. PLoS One (2012) 1.18
Neurobehavioural correlates of body mass index and eating behaviours in adults: a systematic review. Neurosci Biobehav Rev (2012) 1.15
Bariatric surgery patients exhibit improved memory function 12 months postoperatively. Obes Surg (2013) 0.99
Long-term impact of behavioral weight loss intervention on cognitive function. J Gerontol A Biol Sci Med Sci (2014) 0.98
Is obesity associated with a decline in intelligence quotient during the first half of the life course? Am J Epidemiol (2013) 0.97
Neuropsychiatric comorbidity in obesity: role of inflammatory processes. Front Endocrinol (Lausanne) (2014) 0.95
Food reward system: current perspectives and future research needs. Nutr Rev (2015) 0.92
Aerobic fitness and body mass index in individuals with schizophrenia: Implications for neurocognition and daily functioning. Psychiatry Res (2014) 0.86
Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity. Front Neurosci (2015) 0.85
Effect of weight loss, exercise, or both on cognition and quality of life in obese older adults. Am J Clin Nutr (2014) 0.82
Spatial reference memory in normal aging Fischer 344 × Brown Norway F1 hybrid rats. Neurobiol Aging (2014) 0.81
Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits. BMC Med (2012) 0.81
Lifestyle factors associated with cognitive functioning in breast cancer survivors. Psychooncology (2014) 0.80
Obesity and Aging: Consequences for Cognition, Brain Structure, and Brain Function. Psychosom Med (2015) 0.80
Objectively measured physical activity and cognitive functioning in breast cancer survivors. J Cancer Surviv (2014) 0.80
Treatment of obesity and disability in schizophrenia. Innov Clin Neurosci (2013) 0.80
Neuropsychological function in individuals with morbid obesity: a cross-sectional study. BMC Obes (2017) 0.78
Surgical and Nonsurgical Interventions for Obesity in Service of Preserving Cognitive Function. Psychosom Med (2015) 0.78
Dietary Factors and Cognitive Decline. J Prev Alzheimers Dis (2016) 0.78
Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma. EBioMedicine (2015) 0.77
Effect of a Long-Term Intensive Lifestyle Intervention on Cognitive Function: Action for Health in Diabetes Study. J Am Geriatr Soc (2017) 0.77
Control of adult neurogenesis by programmed cell death in the mammalian brain. Mol Brain (2016) 0.76
Obesity, Cardiovascular Fitness, and Inhibition Function: An Electrophysiological Study. Front Psychol (2016) 0.75
Modulation of Irisin and Physical Activity on Executive Functions in Obesity and Morbid obesity. Sci Rep (2016) 0.75
Perceived cognitive function for breast cancer survivors: association of genetic and behaviorally related variables for inflammation. Support Care Cancer (2017) 0.75
Psychological and neural contributions to appetite self-regulation. Obesity (Silver Spring) (2017) 0.75
Body-Brain Connections: The Effects of Obesity and Behavioral Interventions on Neurocognitive Aging. Front Aging Neurosci (2017) 0.75
A Mediterranean Diet to Improve Cardiovascular and Cognitive Health: Protocol for a Randomised Controlled Intervention Study. Nutrients (2017) 0.75
Similar effects on cognitive performance during high- and low-carbohydrate obesity treatment. Nutr Diabetes (2013) 0.75
Dance Experience and Associations with Cortical Gray Matter Thickness in the Aging Population. Dement Geriatr Cogn Dis Extra (2016) 0.75
Executive function in weight loss and weight loss maintenance: a conceptual review and novel neuropsychological model of weight control. J Behav Med (2017) 0.75
Long-term impact of intensive lifestyle intervention on cognitive function assessed with the National Institutes of Health Toolbox: The Look AHEAD study. Alzheimers Dement (Amst) (2017) 0.75
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
MIPS: analysis and annotation of proteins from whole genomes. Nucleic Acids Res (2004) 8.58
The prevalence of frontotemporal dementia. Neurology (2002) 5.73
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95
The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol (1991) 3.70
Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet (1998) 3.03
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
Congenital heart disease among 160 480 liveborn children in Liverpool 1960 to 1969. Implications for surgical treatment. Br Heart J (1981) 2.80
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49
Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF. Mol Cell Biol (1997) 2.37
The conducting tissues in congenitally corrected transposition. Circulation (1974) 2.27
Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. Blood (1994) 2.16
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria. J Exp Med (1982) 2.12
Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest (1996) 2.10
Results of balloon pulmonary valvuloplasty as a palliative procedure in tetralogy of Fallot. J Am Coll Cardiol (1991) 2.10
Physicians' attitudes toward using deception to resolve difficult ethical problems. JAMA (1989) 2.09
Dissecting human T cell responses against Bordetella species. J Exp Med (1988) 2.07
Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion (1995) 2.05
Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest (1992) 2.00
Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem (1997) 1.97
Transcatheter occlusion of the patent ductus arteriosus with Cook detachable coils. Heart (1996) 1.91
Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol (1991) 1.89
De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation (2001) 1.88
Dementia and survival in Parkinson disease: a 12-year population study. Neurology (2008) 1.86
Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice. J Immunol (1983) 1.82
Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat Genet (1999) 1.79
The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol (2000) 1.77
Risk of mortality, cancer incidence, and stroke in a population potentially exposed to cadmium. Occup Environ Med (2000) 1.77
Quantitation of rhythmic diameter changes in arterial microcirculation. Am J Physiol (1984) 1.77
Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology (2008) 1.76
Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production. J Immunol (1984) 1.75
Transcriptional repression by the insulator protein CTCF involves histone deacetylases. Nucleic Acids Res (2000) 1.74
Natural killer activity of gut mucosal lymphoid cells in mice. Eur J Immunol (1981) 1.73
Morphological characterization of a cell population responsible for natural killer activity. Immunology (1981) 1.73
Sarcopenic obesity: A Critical appraisal of the current evidence. Clin Nutr (2012) 1.73
Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA. Nature (1984) 1.71
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol Oncol Clin North Am (2000) 1.69
Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans. J Clin Invest (1998) 1.68
Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry (1994) 1.66
Mild cognitive impairment: a concept in evolution. J Intern Med (2014) 1.65
Cardiac angiosarcoma: case report and review of the literature. Z Kardiol (2005) 1.65
Influence of feeding and sham feeding upon serum gastrin and gastric acid secretion in control subjects and duodenal ulcer patients. Scand J Gastroenterol (1974) 1.63
Stroke, vascular risk factors and depression: Cross-sectional study in a UK Caribbean-born population. Br J Psychiatry (2001) 1.62
The impact on prevalence of dementia in the oldest age groups of differential mortality patterns: a deterministic approach. Int J Epidemiol (1998) 1.62
CAMCOG--a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. Br J Clin Psychol (1995) 1.62
Exploring the impact of prevalence and mortality on incidence of dementia in the oldest old: the sensitivity of a deterministic approach. Neuroepidemiology (2001) 1.60
Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. N Engl J Med (1992) 1.59
Assessing the acceptability and feasibility of the MEND Programme in a small group of obese 7-11-year-old children. J Hum Nutr Diet (2005) 1.59
Multi-frequency impedance for the prediction of extracellular water and total body water. Br J Nutr (1995) 1.57
Morphogenesis of bulboventricular malformations. I. Consideration of embryogenesis in the normal heart. Br Heart J (1974) 1.57
Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology (1997) 1.56
Gastrin and G-cells in the antral mucosa of patients with pernicious anaemia, acromegaly and hyperparathyroidism and in a Zollinger-Ellison tumour of the pancreas. Eur J Clin Invest (1971) 1.52
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia. Ann Hematol (1994) 1.51
Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map. J Exp Med (1989) 1.49
A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand (2006) 1.49
Cognition and survival: an exploration in a large multicentre study of the population aged 65 years and over. Int J Epidemiol (2001) 1.48
Angiogenesis and biomarkers of cardiovascular risk in adults with metabolic syndrome. J Intern Med (2010) 1.48
Increased fructose intake as a risk factor for dementia. J Gerontol A Biol Sci Med Sci (2010) 1.48
Coarctation co-existing with tetralogy of Fallot and pulmonary atresia. Cardiol Young (2001) 1.47
From fate to tragedy: the changing meanings of life, death, and AIDS. Ann Intern Med (1998) 1.46
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2011) 1.46
Morphogenesis of bulboventricular malformations. II. Observations on malformed hearts. Br Heart J (1974) 1.45
Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy. Bone Marrow Transplant (2001) 1.44
Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. Brain (2009) 1.43
Natural cytotoxicity of mouse monocytes and macrophages. J Immunol (1979) 1.43
Mucosal gastrin concentration, molecular forms of gastrin, number and ultrastructure of G-cells in patients with duodenal ulcer. Gut (1976) 1.42
Effect of smoking on global cognitive function in nondemented elderly. Neurology (2004) 1.42
Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut (2009) 1.40
First description of three patients with multifocal lymphangiomatosis and protein-losing enteropathy following palliation of complex congenital heart disease with total cavo-pulmonary connection. Pediatr Cardiol (2008) 1.39
Profile of disability in elderly people: estimates from a longitudinal population study. BMJ (1999) 1.38
A national facility for small area disease mapping and rapid initial assessment of apparent disease clusters around a point source: the UK Small Area Health Statistics Unit. J Public Health Med (1999) 1.38
Increasing organ donation in the African-American community: altruism in the face of an untrustworthy system. Ann Intern Med (1999) 1.37
Understanding social dysfunction in the behavioural variant of frontotemporal dementia: the role of emotion and sarcasm processing. Brain (2009) 1.37
Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant (2005) 1.37
Balloon dilatation of the arterial duct in congenital heart disease. Lancet (1992) 1.35
Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging (2008) 1.35
Population norms for the MMSE in the very old: estimates based on longitudinal data. Mini-Mental State Examination. Neurology (2000) 1.35
Cardiac specialized tissue in hearts with an apparently single ventricular chamber (double inlet left ventricle). Am J Cardiol (1974) 1.33
Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort. Neurology (2008) 1.32
Outcome of treatment for neonates referred to a supraregional cardiac centre 1976-78. Arch Dis Child (1982) 1.31
Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis. Infect Immun (1991) 1.31
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis (2004) 1.30
A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. J Immunol (1986) 1.30
IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine. J Immunol (1986) 1.30
Smoking, drinking, and other life style factors and cognitive function in men in the Caerphilly cohort. J Epidemiol Community Health (1999) 1.30
Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J Immunol (2000) 1.29
Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. Mol Endocrinol (2001) 1.29
Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am J Pathol (2000) 1.28
Balloon dilatation of the pulmonary valve in the first year of life in patients with tetralogy of Fallot: a preliminary study. Br Heart J (1988) 1.27
Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood (1996) 1.26
IgA-dependent cell-mediated activity against enteropathogenic bacteria: distribution, specificity, and characterization of the effector cells. J Immunol (1984) 1.24
Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve. Digestion (1995) 1.23